Activity Dates: 02/03/2014 - 02/03/2016
This course is closed. Please look for other available products in CPNP University.
If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.
This self-study course is designed to assist the learner in developing and maintaining contemporary knowledge and skills in the pharmacotherapy management of pediatric related diseases. Content includes a comprehensive outline and author presentation focused on etiology, risk factors, pathophysiology and treatment of pediatric related diseases. Specific focus is placed on identifying common signs and symptoms based on DSM-5 criteria, resolving drug therapy problems and developing an appropriate monitoring plan.
You will proceed through the following steps to satisfactorily complete this course:
This course is provided online at cpnp.org and is available to participants through the course expiration date. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe. ACCME statements are printable immediately upon successful completion of this course.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows Vista and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Sandra Mullen, PharmD, BCPPView biographical information and disclosures
Continuing Pharmacy Education Credit
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.5 contact hours (0.15 CEUs) of knowledge-based continuing education credit. The ACPE universal program number assigned to this course is 0284-9999-14-041-H01-P (1.5 contact hours).
Continuing Medical Education Credit
Creative Educational Concepts, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CEC designates this enduring material educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Megan J. Ehret, PharmD, MS, BCPP
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Barrons PCAT Review Book Evaluator, PSAP Book Chapter Author
Educational Grants, Research Grants or Contracts: American Society of Health System Pharmacists Research Foundation Grant
Non-Financial Interests: Board of Directors of CPNP
Cynthia K. Kirkwood, PharmD, BCPP
BCPP Program Director
Professor, Vice Chair for Education
Virginia Commonwealth University
|No Relevant Financial Relationships to Disclose|
Eric C. Kutscher, PharmD, BCPP, FASHP
Assistant Director of Pharmacy, Clinical Services
University of Arizona Health Network
Associate Professor of Pharmacy Practice and Science
University of Arizona College of Pharmacy
|No Relevant Financial Relationships to Disclose|
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is supported by an educational grant from Lilly and Sunovion Pharmaceuticals Inc. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.